Pub Date : 2023-12-01Epub Date: 2023-11-30DOI: 10.1080/08037051.2023.2288313
Hoang Thi Hai Van, Dang Thi Huong, Tran Ngoc Anh
Background: This study aims to determine the validity of self-reported hypertension and identify factors affecting the disagreement between self-reported hypertension and objective measures of blood pressure among adults in Vietnam.
Materials and methods: A total of 4,219 people aged 18 and older reported their hypertension status and had their blood pressure measured. The inter-reliability between self-reported and measured hypertension was assessed using Cohen's Kappa statistics. Univariate and multivariate logistic regressions were used to examine the affecting factors of disagreement.
Result: Self-reported hypertension prevalence was 13.2% (557/4,219), while measured hypertension was 20.9% (881/4,219). An agreement between self-reported and measured data was moderate for the hypertension of participants (κ = 0.39, 95% CI 0.36-0.43). Self-reported hypertension showed high specificity (93.9%) (95% CI 93.0-94.7) but low sensitivity (40.1%; 95 CI 36.8-43.4). The percentage of disagreement in hypertension (number of false positives and false negatives between self-reported and measured data) among adults in Vietnam was 17.3%.
Conclusion: Our findings showed there was a high disagreement percentage of hypertension between self-reported and measured data. This is the first report of this issue to warn of health risks if high blood pressure is not detected early. The disagreement of hypertension was observed more frequently in men, people older than 40, minority ethnic groups, farmers, and people with a BMI greater than 25 kg/m2.
背景:本研究旨在确定越南成年人自我报告高血压的有效性,并确定影响自我报告高血压与客观血压测量不一致的因素。材料和方法:共有4219名18岁及以上的人报告了他们的高血压状况并测量了他们的血压。采用Cohen's Kappa统计评估自我报告和测量高血压之间的相互信度。采用单变量和多变量logistic回归来检验分歧的影响因素。结果:自报高血压患病率为13.2%(557/ 4219),实测高血压患病率为20.9%(881/ 4219)。参与者的高血压自我报告和测量数据之间的一致性为中等(κ = 0.39, 95% CI 0.36-0.43)。自我报告的高血压显示高特异性(93.9%)(95% CI 93.0-94.7),但低敏感性(40.1%;95 ci 36.8-43.4)。越南成年人对高血压的不一致百分比(自我报告和测量数据之间的假阳性和假阴性数量)为17.3%。结论:我们的研究结果显示,自我报告的高血压和测量数据之间存在很大的不一致百分比。这是该问题的第一份报告,警告如果不及早发现高血压会带来的健康风险。在男性、40岁以上、少数民族、农民和BMI大于25 kg/m2的人群中,高血压的不一致更为常见。
{"title":"Validity of self-reported hypertension and associated factors among Vietnamese adults: a cross-sectional study.","authors":"Hoang Thi Hai Van, Dang Thi Huong, Tran Ngoc Anh","doi":"10.1080/08037051.2023.2288313","DOIUrl":"10.1080/08037051.2023.2288313","url":null,"abstract":"<p><strong>Background: </strong>This study aims to determine the validity of self-reported hypertension and identify factors affecting the disagreement between self-reported hypertension and objective measures of blood pressure among adults in Vietnam.</p><p><strong>Materials and methods: </strong>A total of 4,219 people aged 18 and older reported their hypertension status and had their blood pressure measured. The inter-reliability between self-reported and measured hypertension was assessed using Cohen's Kappa statistics. Univariate and multivariate logistic regressions were used to examine the affecting factors of disagreement.</p><p><strong>Result: </strong>Self-reported hypertension prevalence was 13.2% (557/4,219), while measured hypertension was 20.9% (881/4,219). An agreement between self-reported and measured data was moderate for the hypertension of participants (κ = 0.39, 95% CI 0.36-0.43). Self-reported hypertension showed high specificity (93.9%) (95% CI 93.0-94.7) but low sensitivity (40.1%; 95 CI 36.8-43.4). The percentage of disagreement in hypertension (number of false positives and false negatives between self-reported and measured data) among adults in Vietnam was 17.3%.</p><p><strong>Conclusion: </strong>Our findings showed there was a high disagreement percentage of hypertension between self-reported and measured data. This is the first report of this issue to warn of health risks if high blood pressure is not detected early. The disagreement of hypertension was observed more frequently in men, people older than 40, minority ethnic groups, farmers, and people with a BMI greater than 25 kg/m<sup>2</sup>.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":"32 1","pages":"2288313"},"PeriodicalIF":1.8,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138457607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-12-01DOI: 10.1080/08037051.2023.2243337
Honglv Xu, Wei Wang, Min Wang, Junyu Chen, Chunjie Yu, Min Li, Dehui Liu, Jiai Wang, Yinghong Jiang
Purpose: Previous studies have indicated that the prevalence rate of hypertension in adolescents is high, but it has not received much attention and the influencing factors are unclear, especially in Yunnan Province, China.
Materials and methods: A cluster sampling method was used to investigate 4781 freshmen in a college in Kunming, Yunnan Province from November to December. Demographic and lifestyle data were collected using questionnaires, and height, weight and blood pressure were measured. Decision tree model of hypertension in college students was established by Chi-square automatic interactive detection method.
Results: Prevalence of prehypertension of systolic blood pressure (SBP) and diastolic blood pressure (DBP) were detected in 33.9% and 32.1%, respectively. Prevalence of hypertension of SBP and DBP was detected in 1.2% and 7.2%, respectively. The hypertension and prehypertension decision tree of SBP has gender (χ2 = 728.64, p < .001) at the first level and body mass index (BMI) (boys: χ2 = 55.98, p < .001; girls: χ2 = 79.58, p < .001) at the second level. The hypertension and prehypertension decision tree of DBP has gender (χ2 = 381.83, p < .001) at the first level, BMI (boys: χ2 = 40.54, p < .001; girls: χ2 = 48.79, p < .001) at the second level, only children (χ2 = 6.43, p = .04) and red wine consumption (χ2 = 8.17, p = .017) at the third level.
Conclusions: The present study suggests that gender, BMI, only children and red wine consumption were the main factors affecting hypertension in college students in southwest border areas of China.
{"title":"A decision tree model of hypertension among college students in Yunnan Province, China.","authors":"Honglv Xu, Wei Wang, Min Wang, Junyu Chen, Chunjie Yu, Min Li, Dehui Liu, Jiai Wang, Yinghong Jiang","doi":"10.1080/08037051.2023.2243337","DOIUrl":"10.1080/08037051.2023.2243337","url":null,"abstract":"<p><strong>Purpose: </strong>Previous studies have indicated that the prevalence rate of hypertension in adolescents is high, but it has not received much attention and the influencing factors are unclear, especially in Yunnan Province, China.</p><p><strong>Materials and methods: </strong>A cluster sampling method was used to investigate 4781 freshmen in a college in Kunming, Yunnan Province from November to December. Demographic and lifestyle data were collected using questionnaires, and height, weight and blood pressure were measured. Decision tree model of hypertension in college students was established by Chi-square automatic interactive detection method.</p><p><strong>Results: </strong>Prevalence of prehypertension of systolic blood pressure (SBP) and diastolic blood pressure (DBP) were detected in 33.9% and 32.1%, respectively. Prevalence of hypertension of SBP and DBP was detected in 1.2% and 7.2%, respectively. The hypertension and prehypertension decision tree of SBP has gender (<i>χ</i><sup>2</sup> = 728.64, <i>p <</i> .001) at the first level and body mass index (BMI) (boys: <i>χ</i><sup>2</sup> = 55.98, <i>p <</i> .001; girls: <i>χ</i><sup>2</sup> = 79.58, <i>p <</i> .001) at the second level. The hypertension and prehypertension decision tree of DBP has gender (<i>χ</i><sup>2</sup> = 381.83, <i>p <</i> .001) at the first level, BMI (boys: <i>χ</i><sup>2</sup> = 40.54, <i>p <</i> .001; girls: <i>χ</i><sup>2</sup> = 48.79, <i>p <</i> .001) at the second level, only children (<i>χ</i><sup>2</sup> = 6.43, <i>p =</i> .04) and red wine consumption (<i>χ</i><sup>2</sup> = 8.17, <i>p =</i> .017) at the third level.</p><p><strong>Conclusions: </strong>The present study suggests that gender, BMI, only children and red wine consumption were the main factors affecting hypertension in college students in southwest border areas of China.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":"32 1","pages":"2243337"},"PeriodicalIF":1.8,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10115182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-12-01Epub Date: 2023-10-07DOI: 10.1080/08037051.2023.2266664
Kyriakos Dimitriadis, Roland E Schmieder, Panagiotis Iliakis, Laura Nickel, Konstantinos Tsioufis, Joachim Weil
Hypertension remains the leading treatable global cause of mortality due to high incidence and poor control rates despite of safe and effective drug therapy.Animal studies do not support functional nerve regrowth after RF-RDN and accordingly clinical evidence verify that RDN leads to durable BP reduction.Renal denervation is safe, as up to 36 months after the procedure, there are no statistically significant difference in procedure-related adverse events, deterioration of renal function and adverse cardiovascular outcomeRenal denervation is efficient in reducing BP in patients with no drug therapy, independently of the number of antihypertensive drugs and phenotype of patient. This sustained and safe reduction in BP observed up to 36 months after RDN could be associated with lower rates of renal and cardiovascular events.
{"title":"Long-term efficacy and safety of renal denervation: an update from registries and randomised trials.","authors":"Kyriakos Dimitriadis, Roland E Schmieder, Panagiotis Iliakis, Laura Nickel, Konstantinos Tsioufis, Joachim Weil","doi":"10.1080/08037051.2023.2266664","DOIUrl":"10.1080/08037051.2023.2266664","url":null,"abstract":"Hypertension remains the leading treatable global cause of mortality due to high incidence and poor control rates despite of safe and effective drug therapy.Animal studies do not support functional nerve regrowth after RF-RDN and accordingly clinical evidence verify that RDN leads to durable BP reduction.Renal denervation is safe, as up to 36 months after the procedure, there are no statistically significant difference in procedure-related adverse events, deterioration of renal function and adverse cardiovascular outcomeRenal denervation is efficient in reducing BP in patients with no drug therapy, independently of the number of antihypertensive drugs and phenotype of patient. This sustained and safe reduction in BP observed up to 36 months after RDN could be associated with lower rates of renal and cardiovascular events.","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":"32 1","pages":"2266664"},"PeriodicalIF":1.8,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41149310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-12-01Epub Date: 2023-10-20DOI: 10.1080/08037051.2023.2270070
D Collard, E M C Vriend, H Galenkamp, E P Moll van Charante, L Vogt, B E Westerhof, B J H van den Born
Background: Hypertension can be classified into different phenotypes based on systolic and diastolic blood pressure (BP) that carry a different prognosis and may therefore be differently associated with sympathetic activity. We assessed the association between cardiac autonomic function determined from continuous finger BP recordings and hypertensive phenotypes. Methods: We included 10,221 individuals aged between 18-70 years from the multi-ethnic HELIUS study. Finger BP was recorded continuously for 3-5 minutes from which cross-correlation baroreflex sensitivity (xBRS) and heart rate variability (HRV) were determined. Hypertension was classified into isolated systolic (ISH; ≥140/<90), diastolic (IDH; <140/≥90) and combined systolic and diastolic hypertension (SDH; ≥140/≥90). Differences were assessed after stratification by age (younger: ≤40, older: >40 years) and sex, using regression with correction for relevant covariates. For xBRS, values were log-transformed. Results: In younger adults with ISH, xBRS was comparable to normotensive individuals in men (ratio 0.92; 95%CI 0.84-1.01) and women (1.00; 95%CI 0.84-1.20), while xBRS was significantly lower in IDH and SDH (ratios between 0.67 and 0.80). In older adults, all hypertensive phenotypes had significantly lower xBRS compared to normotensives. We found a similar pattern for HRV in men, while in women HRV did not differ between phenotypes. Conclusions: In younger men and women ISH is not associated with a shift towards increased sympathetic control, while IDH and SDH in younger and all hypertensive phenotypes in older participants were associated with increased sympathetic control. This suggests that alterations in autonomic regulation could be a contributing factor to known prognostic disparities between hypertensive phenotypes.
{"title":"Autonomic regulation in different hypertensive phenotypes - the HELIUS study.","authors":"D Collard, E M C Vriend, H Galenkamp, E P Moll van Charante, L Vogt, B E Westerhof, B J H van den Born","doi":"10.1080/08037051.2023.2270070","DOIUrl":"10.1080/08037051.2023.2270070","url":null,"abstract":"Background: Hypertension can be classified into different phenotypes based on systolic and diastolic blood pressure (BP) that carry a different prognosis and may therefore be differently associated with sympathetic activity. We assessed the association between cardiac autonomic function determined from continuous finger BP recordings and hypertensive phenotypes. Methods: We included 10,221 individuals aged between 18-70 years from the multi-ethnic HELIUS study. Finger BP was recorded continuously for 3-5 minutes from which cross-correlation baroreflex sensitivity (xBRS) and heart rate variability (HRV) were determined. Hypertension was classified into isolated systolic (ISH; ≥140/<90), diastolic (IDH; <140/≥90) and combined systolic and diastolic hypertension (SDH; ≥140/≥90). Differences were assessed after stratification by age (younger: ≤40, older: >40 years) and sex, using regression with correction for relevant covariates. For xBRS, values were log-transformed. Results: In younger adults with ISH, xBRS was comparable to normotensive individuals in men (ratio 0.92; 95%CI 0.84-1.01) and women (1.00; 95%CI 0.84-1.20), while xBRS was significantly lower in IDH and SDH (ratios between 0.67 and 0.80). In older adults, all hypertensive phenotypes had significantly lower xBRS compared to normotensives. We found a similar pattern for HRV in men, while in women HRV did not differ between phenotypes. Conclusions: In younger men and women ISH is not associated with a shift towards increased sympathetic control, while IDH and SDH in younger and all hypertensive phenotypes in older participants were associated with increased sympathetic control. This suggests that alterations in autonomic regulation could be a contributing factor to known prognostic disparities between hypertensive phenotypes.","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":"32 1","pages":"2270070"},"PeriodicalIF":1.8,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49674028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-12-01Epub Date: 2023-10-26DOI: 10.1080/08037051.2023.2274595
Sondre Heimark, Christine Hove, Alexey Stepanov, Elin Sundby Boysen, Øyvind Gløersen, Kasper Gade Bøtke-Rasmussen, Hans Jacob Gravdal, Kesi Narayanapillai, Fadl Elmula M Fadl Elmula, Trine M Seeberg, Anne Cecilie K Larstorp, Bård Waldum-Grevbo
Objective: 24-hour ambulatory blood pressure monitoring (24ABPM) is state of the art in out-of-office blood pressure (BP) monitoring. Due to discomfort and technical limitations related to cuff-based 24ABPM devices, methods for non-invasive and continuous estimation of BP without the need for a cuff have gained interest. The main aims of the present study were to compare accuracy of a pulse arrival time (PAT) based BP-model and user acceptability of a prototype cuffless multi-sensor device (cuffless device), developed by Aidee Health AS, with a conventional cuff-based oscillometric device (ReferenceBP) during 24ABPM.
Methods: Ninety-five normotensive and hypertensive adults underwent simultaneous 24ABPM with the cuffless device on the chest and a conventional cuff-based oscillometric device on the non-dominant arm. PAT was calculated using the electrocardiogram (ECG) and photoplethysmography (PPG) sensors incorporated in the chest-worn device. The cuffless device recorded continuously, while ReferenceBP measurements were taken every 20 minutes during daytime and every 30 minutes during nighttime. Two-minute PAT-based BP predictions corresponding to the ReferenceBP measurements were compared with ReferenceBP measurements using paired t-tests, bias, and limits of agreement.
Results: Mean (SD) of ReferenceBP compared to PAT-based daytime and nighttime systolic BP (SBP) were 129.7 (13.8) mmHg versus 133.6 (20.9) mmHg and 113.1 (16.5) mmHg versus 131.9 (23.4) mmHg. Ninety-five % limits of agreements were [-26.7, 34.6 mmHg] and [-20.9, 58.4 mmHg] for daytime and nighttime SBP respectively. The cuffless device was reported to be significantly more comfortable and less disturbing than the ReferenceBP device during 24ABPM.
Conclusions: In the present study, we demonstrated that a general PAT-based BP model had unsatisfactory agreement with ambulatory BP during 24ABPM, especially during nighttime. If sufficient accuracy can be achieved, cuffless BP devices have promising potential for clinical assessment of BP due to the opportunities provided by continuous BP measurements during real-life conditions and high user acceptability.
目的:24小时动态血压监测(24ABPM)是目前最先进的非办公室血压监测方法。由于与基于袖带的24ABPM装置相关的不适和技术限制,在不需要袖带的情况下无创和连续估计血压的方法已经引起了人们的兴趣。本研究的主要目的是比较基于脉冲到达时间(PAT)的BP模型的准确性和Aidee Health AS开发的原型无袖带多传感器设备(无袖带设备)的用户可接受性,方法:95名血压正常和高血压的成年人同时接受了24ABPM,在胸部使用无袖带装置,在非优势臂使用常规袖带示波装置。PAT是使用结合在胸部佩戴设备中的心电图(ECG)和光体积描记术(PPG)传感器计算的。无袖带设备连续记录,而ReferenceBP测量每20次 白天每30分钟 分钟。使用配对t检验、偏倚和一致性极限,将与ReferenceBP测量相对应的基于两分钟PAT的BP预测与ReferenceBB测量进行比较。结果:与基于PAT的日间和夜间收缩压(SBP)相比,参考血压的平均值(SD)分别为129.7(13.8)mmHg和133.6(20.9)mmHg,113.1(16.5)mmHg与131.9(23.4)mm汞柱。95%的协议限制为[-26.7,34.6 mmHg]和[-20.9,58.4 mmHg]。据报道,在24ABPM期间,无袖套装置比ReferenceBP装置明显更舒适,干扰更小。结论:在本研究中,我们证明了基于PAT的通用BP模型在24ABPM期间,尤其是在夜间,与动态BP的一致性不令人满意。如果能够实现足够的准确性,无套BP设备具有很好的临床评估BP的潜力,因为在现实生活条件下连续测量BP提供了机会,并且用户可接受性很高。
{"title":"Accuracy and User Acceptability of 24-hour Ambulatory Blood Pressure Monitoring by a Prototype Cuffless Multi-Sensor Device Compared to a Conventional Oscillometric Device.","authors":"Sondre Heimark, Christine Hove, Alexey Stepanov, Elin Sundby Boysen, Øyvind Gløersen, Kasper Gade Bøtke-Rasmussen, Hans Jacob Gravdal, Kesi Narayanapillai, Fadl Elmula M Fadl Elmula, Trine M Seeberg, Anne Cecilie K Larstorp, Bård Waldum-Grevbo","doi":"10.1080/08037051.2023.2274595","DOIUrl":"10.1080/08037051.2023.2274595","url":null,"abstract":"<p><strong>Objective: </strong>24-hour ambulatory blood pressure monitoring (24ABPM) is state of the art in out-of-office blood pressure (BP) monitoring. Due to discomfort and technical limitations related to cuff-based 24ABPM devices, methods for non-invasive and continuous estimation of BP without the need for a cuff have gained interest. The main aims of the present study were to compare accuracy of a pulse arrival time (PAT) based BP-model and user acceptability of a prototype cuffless multi-sensor device (cuffless device), developed by Aidee Health AS, with a conventional cuff-based oscillometric device (ReferenceBP) during 24ABPM.</p><p><strong>Methods: </strong>Ninety-five normotensive and hypertensive adults underwent simultaneous 24ABPM with the cuffless device on the chest and a conventional cuff-based oscillometric device on the non-dominant arm. PAT was calculated using the electrocardiogram (ECG) and photoplethysmography (PPG) sensors incorporated in the chest-worn device. The cuffless device recorded continuously, while ReferenceBP measurements were taken every 20 minutes during daytime and every 30 minutes during nighttime. Two-minute PAT-based BP predictions corresponding to the ReferenceBP measurements were compared with ReferenceBP measurements using paired t-tests, bias, and limits of agreement.</p><p><strong>Results: </strong>Mean (SD) of ReferenceBP compared to PAT-based daytime and nighttime systolic BP (SBP) were 129.7 (13.8) mmHg versus 133.6 (20.9) mmHg and 113.1 (16.5) mmHg versus 131.9 (23.4) mmHg. Ninety-five % limits of agreements were [-26.7, 34.6 mmHg] and [-20.9, 58.4 mmHg] for daytime and nighttime SBP respectively. The cuffless device was reported to be significantly more comfortable and less disturbing than the ReferenceBP device during 24ABPM.</p><p><strong>Conclusions: </strong>In the present study, we demonstrated that a general PAT-based BP model had unsatisfactory agreement with ambulatory BP during 24ABPM, especially during nighttime. If sufficient accuracy can be achieved, cuffless BP devices have promising potential for clinical assessment of BP due to the opportunities provided by continuous BP measurements during real-life conditions and high user acceptability.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":"32 1","pages":"2274595"},"PeriodicalIF":1.8,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54227595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-12-01Epub Date: 2023-10-14DOI: 10.1080/08037051.2023.2269431
Thomas Weber, Michael Doumas, Christian Delles, Bojan Jelakovic, Margus Viigimaa, Krzysztof Narkiewicz, Andrzej Januszewicz, Reinhold Kreutz, Guido Grassi, Giuseppe Mancia
Purpose: To describe the history of the Excellence Centre (EC) programme of the European Society of Hypertension (ESH) since the beginning in 2006, its achievements, and its future developments.
Materials and methods: We list the number of ECs per country, the research projects performed so far, and the organisational steps needed to reshape the EC programme for the future.
Results: In August 2023, the ESH EC programme includes 118 registered ECs in 21 European and 7 non-European countries. Updates about the formal steps for application, re-application, transfer of EC and retirement of EC heads are given.
Conclusions: The EC programme of the ESH has been a success from the beginning. Further refinements will make it fit for the next decades.
{"title":"The Hypertension Excellence Centre programme of the European Society of Hypertension - current status, activities and reshaping for the future.","authors":"Thomas Weber, Michael Doumas, Christian Delles, Bojan Jelakovic, Margus Viigimaa, Krzysztof Narkiewicz, Andrzej Januszewicz, Reinhold Kreutz, Guido Grassi, Giuseppe Mancia","doi":"10.1080/08037051.2023.2269431","DOIUrl":"10.1080/08037051.2023.2269431","url":null,"abstract":"<p><strong>Purpose: </strong>To describe the history of the Excellence Centre (EC) programme of the European Society of Hypertension (ESH) since the beginning in 2006, its achievements, and its future developments.</p><p><strong>Materials and methods: </strong>We list the number of ECs per country, the research projects performed so far, and the organisational steps needed to reshape the EC programme for the future.</p><p><strong>Results: </strong>In August 2023, the ESH EC programme includes 118 registered ECs in 21 European and 7 non-European countries. Updates about the formal steps for application, re-application, transfer of EC and retirement of EC heads are given.</p><p><strong>Conclusions: </strong>The EC programme of the ESH has been a success from the beginning. Further refinements will make it fit for the next decades.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":"32 1","pages":"2269431"},"PeriodicalIF":1.8,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41190297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-12-01DOI: 10.1080/08037051.2022.2091977
Liana K Preudhomme, Marc D Gellman, Nora Franceschini, Krista M Perreira, Lindsay E Fernández-Rhodes, Linda C Gallo, Carmen R Isasi, Sylvia Smoller, Sheila F Castañeda, Martha Daviglus, Christina Hutten, Richard S Cooper, Jianwen Cai, Neil Schneiderman, Maria M Llabre
Purpose: The current study examined the effects of chronic stress and a genetic risk score on the presence of hypertension and elevated systolic blood pressure and diastolic blood pressure among Hispanics/Latinos in the target population of Hispanic Community Health Study/Study of Latinos.
Materials and methods: Of the participants (N = 11,623) assessed during two clinic visits (Visit 1 2008-2013 & Visit 2 2014-2018), we analysed data from 7,429 adults (50.4% female), aged 18-74, who were genotyped and responded to chronic stress questionnaires. We calculated an unweighted genetic risk score using blood pressure increasing single nucleotide polymorphisms (SNPs) found to be generalisable to Hispanics/Latinos (10 SNPs). Linear and logistic regression models were used to estimate associations between chronic stress and genetic risk score and their interaction, with prevalent Visit 2 SBP or DBP, and hypertension, respectively. Models accounted for sampling weights, stratification, and cluster design.
Results: Chronic stress (adjusted OR = 1.18, 95%CI:1.15,1.22) and hypertension genetic risk score (adjusted OR = 1.04, 95%CI:1.01,1.07) were significantly associated with prevalent hypertension, but there was no significant interaction between the chronic stress and genetic risk score on hypertension (p = .49). genetic risk score (b = .32, 95%CI:.08, .55, R2 = .02) and chronic stress (b = .45, 95%CI:.19, .72, R2 = .11) were related to DBP, with no significant interaction (p = .62). Genetic risk score (b = .42, 95%CI:.08, .76, R2 = .01) and chronic stress (b = .80, 95%CI:.34,1.26, R2 = .11) were also related to SBP, with no significant interaction (p = .51).
Conclusion: Results demonstrate the utility of a genetic risk score for blood pressure and are consistent with literature suggesting chronic stress has a strong, direct association with elevated blood pressure among U.S. Hispanics/Latinos.
{"title":"Genetic and stress influences on the prevalence of hypertension among hispanics/latinos in the hispanic community health study/study of latinos (HCHS/SOL).","authors":"Liana K Preudhomme, Marc D Gellman, Nora Franceschini, Krista M Perreira, Lindsay E Fernández-Rhodes, Linda C Gallo, Carmen R Isasi, Sylvia Smoller, Sheila F Castañeda, Martha Daviglus, Christina Hutten, Richard S Cooper, Jianwen Cai, Neil Schneiderman, Maria M Llabre","doi":"10.1080/08037051.2022.2091977","DOIUrl":"https://doi.org/10.1080/08037051.2022.2091977","url":null,"abstract":"<p><strong>Purpose: </strong>The current study examined the effects of chronic stress and a genetic risk score on the presence of hypertension and elevated systolic blood pressure and diastolic blood pressure among Hispanics/Latinos in the target population of Hispanic Community Health Study/Study of Latinos.</p><p><strong>Materials and methods: </strong>Of the participants (<i>N</i> = 11,623) assessed during two clinic visits (Visit 1 2008-2013 & Visit 2 2014-2018), we analysed data from 7,429 adults (50.4% female), aged 18-74, who were genotyped and responded to chronic stress questionnaires. We calculated an unweighted genetic risk score using blood pressure increasing single nucleotide polymorphisms (SNPs) found to be generalisable to Hispanics/Latinos (10 SNPs). Linear and logistic regression models were used to estimate associations between chronic stress and genetic risk score and their interaction, with prevalent Visit 2 SBP or DBP, and hypertension, respectively. Models accounted for sampling weights, stratification, and cluster design.</p><p><strong>Results: </strong>Chronic stress (adjusted OR = 1.18, 95%CI:1.15,1.22) and hypertension genetic risk score (adjusted OR = 1.04, 95%CI:1.01,1.07) were significantly associated with prevalent hypertension, but there was no significant interaction between the chronic stress and genetic risk score on hypertension (<i>p</i> = .49). genetic risk score (<i>b</i> = .32, 95%CI:.08, .55, <i>R</i><sup>2</sup> = .02) and chronic stress (<i>b</i> = .45, 95%CI:.19, .72, <i>R</i><sup>2</sup> = .11) were related to DBP, with no significant interaction (<i>p</i> = .62). Genetic risk score (<i>b</i> = .42, 95%CI:.08, .76, <i>R</i><sup>2</sup> = .01) and chronic stress (<i>b</i> = .80, 95%CI:.34,1.26, <i>R</i><sup>2</sup> = .11) were also related to SBP, with no significant interaction (<i>p</i> = .51).</p><p><strong>Conclusion: </strong>Results demonstrate the utility of a genetic risk score for blood pressure and are consistent with literature suggesting chronic stress has a strong, direct association with elevated blood pressure among U.S. Hispanics/Latinos.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"155-163"},"PeriodicalIF":1.8,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40406752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-12-01Epub Date: 2021-11-29DOI: 10.1080/08037051.2021.2003699
Joanna Kanarek-Kucner, Beata Graff, Vlasta Bari, Rufus Barraclough, Krzysztof Narkiewicz, Michał Hoffmann
Purpose: Primary aldosteronism is one of the most frequent causes of secondary arterial hypertension, and whether primary aldosteronism is associated with masked hypertension is unknown.
Materials and methods: We describe a 64-year-old man with a history of hypothyroidism, recurring hypokalaemia, and normal home and office blood pressure values. Ambulatory blood pressure monitoring revealed masked hypertension with strikingly high systolic blood pressure variability and typical hypertension-mediated organ damage.
Results: The patient required gradual escalation of antihypertensive medication to four drugs. During the diagnostic process we identified primary aldosteronism, cobalamin deficiency, severe obstructive sleep apnoea, and low baroreflex sensitivity (1.63 ms/mmHg). Following unilateral adrenalectomy, cobalamin supplementation and continuous positive airway pressure, we observed a spectacular improvement in the patient's blood pressure control, baroreflex sensitivity (4.82 ms/mmHg) and quality of life.
Conclusions: We report an unusual case of both masked arterial hypertension and primary aldosteronism. Elevated blood pressure values were masked in home and office measurements by coexisting hypotension which resulted most probably from deteriorated baroreflex sensitivity. Baroreflex sensitivity increased following treatment, including unilateral adrenalectomy. Hypertension can be masked by coexisting baroreceptor dysfunction which may derive from structural but also functional reversible changes.
{"title":"Masked arterial hypertension in a 64-year-old man with primary aldosteronism.","authors":"Joanna Kanarek-Kucner, Beata Graff, Vlasta Bari, Rufus Barraclough, Krzysztof Narkiewicz, Michał Hoffmann","doi":"10.1080/08037051.2021.2003699","DOIUrl":"https://doi.org/10.1080/08037051.2021.2003699","url":null,"abstract":"<p><strong>Purpose: </strong>Primary aldosteronism is one of the most frequent causes of secondary arterial hypertension, and whether primary aldosteronism is associated with masked hypertension is unknown.</p><p><strong>Materials and methods: </strong>We describe a 64-year-old man with a history of hypothyroidism, recurring hypokalaemia, and normal home and office blood pressure values. Ambulatory blood pressure monitoring revealed masked hypertension with strikingly high systolic blood pressure variability and typical hypertension-mediated organ damage.</p><p><strong>Results: </strong>The patient required gradual escalation of antihypertensive medication to four drugs. During the diagnostic process we identified primary aldosteronism, cobalamin deficiency, severe obstructive sleep apnoea, and low baroreflex sensitivity (1.63 ms/mmHg). Following unilateral adrenalectomy, cobalamin supplementation and continuous positive airway pressure, we observed a spectacular improvement in the patient's blood pressure control, baroreflex sensitivity (4.82 ms/mmHg) and quality of life.</p><p><strong>Conclusions: </strong>We report an unusual case of both masked arterial hypertension and primary aldosteronism. Elevated blood pressure values were masked in home and office measurements by coexisting hypotension which resulted most probably from deteriorated baroreflex sensitivity. Baroreflex sensitivity increased following treatment, including unilateral adrenalectomy. Hypertension can be masked by coexisting baroreceptor dysfunction which may derive from structural but also functional reversible changes.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"4-8"},"PeriodicalIF":1.8,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39928057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-12-01DOI: 10.1080/08037051.2022.2118661
Luís Bronze
{"title":"War, hypertension and post traumatic stress disorder. A personal experience.","authors":"Luís Bronze","doi":"10.1080/08037051.2022.2118661","DOIUrl":"https://doi.org/10.1080/08037051.2022.2118661","url":null,"abstract":"","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"225-227"},"PeriodicalIF":1.8,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33454531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Purpose: We investigated whether blood pressure (BP) control measures, visit-to-visit BP variability, and time in therapeutic range (TTR) are associated with future cardiovascular outcomes in hypertensive patients.
Materials and methods: Among 1,408 hypertensive patients without cardiovascular disease, we prospectively evaluated the incident major cardiovascular events over 6 years. In newly diagnosed patients, antihypertensive drug treatment was initiated. We estimated two markers of on-treatment BP control, (1) visit-to-visit BPV as the coefficient of variation of office systolic BP (BP-CV), and (2) TTR calculated as the percentage of office systolic BP measurements within 120-140mmHg across visits.
Results: The hypertensive cohort (672 males, mean age 60 years, 31% newly diagnosed) had a mean systolic/diastolic BP of 142/87 mmHg. The mean number of visits was 4.9 ± 2.6, while the mean attained systolic/diastolic BP during follow-up was 137/79 mmHg using 2.7 ± 1.1 antihypertensive drugs. The BP-CV and TTR were 9.1 ± 4.1% and 45 ± 29%, respectively, and the incidence of the composite outcome was 8.3% (n = 117). After adjustment for relevant confounders and standardization to z-scores, BP-CV and TTR were associated with a 43% (95% CI, 27-62%) increase and a 33% (95% CI, 15-47%) reduction in the outcome. However, the joint evaluation of TTR and BP-CV in a common multivariable model indicated that a standardized change of TTR was associated with the outcome to a greater extent than BP-CV (mean hazard ratios of 30% vs. 24%, respectively). When combined with the higher BP standardized-CV quartile, the lower TTR quartile predicted the outcome by 2.3 times (95% CI, 1.1-5.4) compared to the inverse TTR and BP-CV quartile pattern.
Conclusion: High BP-CV or low TTR was associated with future cardiovascular events in a cohort of treated hypertensive patients. As a determinant, the extent of TTR value appears greater than BP-CV when these measures are considered in the same multivariable model.
{"title":"Blood pressure control measures and cardiovascular outcomes: a prospective hypertensive cohort.","authors":"Konstantinos Sideris, Ioannis Andrikou, Costas Thomopoulos, Fotis Tatakis, Maria Kariori, Eleni Manta, Theodoros Kalos, Stergios Soulaidopoulos, Sotirios Drogkaris, Dimitris Konstantinidis, Konstantinos Tsioufis","doi":"10.1080/08037051.2022.2118662","DOIUrl":"https://doi.org/10.1080/08037051.2022.2118662","url":null,"abstract":"<p><strong>Purpose: </strong>We investigated whether blood pressure (BP) control measures, visit-to-visit BP variability, and time in therapeutic range (TTR) are associated with future cardiovascular outcomes in hypertensive patients.</p><p><strong>Materials and methods: </strong>Among 1,408 hypertensive patients without cardiovascular disease, we prospectively evaluated the incident major cardiovascular events over 6 years. In newly diagnosed patients, antihypertensive drug treatment was initiated. We estimated two markers of on-treatment BP control, (1) visit-to-visit BPV as the coefficient of variation of office systolic BP (BP-CV), and (2) TTR calculated as the percentage of office systolic BP measurements within 120-140mmHg across visits.</p><p><strong>Results: </strong>The hypertensive cohort (672 males, mean age 60 years, 31% newly diagnosed) had a mean systolic/diastolic BP of 142/87 mmHg. The mean number of visits was 4.9 ± 2.6, while the mean attained systolic/diastolic BP during follow-up was 137/79 mmHg using 2.7 ± 1.1 antihypertensive drugs. The BP-CV and TTR were 9.1 ± 4.1% and 45 ± 29%, respectively, and the incidence of the composite outcome was 8.3% (<i>n</i> = 117). After adjustment for relevant confounders and standardization to z-scores, BP-CV and TTR were associated with a 43% (95% CI, 27-62%) increase and a 33% (95% CI, 15-47%) reduction in the outcome. However, the joint evaluation of TTR and BP-CV in a common multivariable model indicated that a standardized change of TTR was associated with the outcome to a greater extent than BP-CV (mean hazard ratios of 30% vs. 24%, respectively). When combined with the higher BP standardized-CV quartile, the lower TTR quartile predicted the outcome by 2.3 times (95% CI, 1.1-5.4) compared to the inverse TTR and BP-CV quartile pattern.</p><p><strong>Conclusion: </strong>High BP-CV or low TTR was associated with future cardiovascular events in a cohort of treated hypertensive patients. As a determinant, the extent of TTR value appears greater than BP-CV when these measures are considered in the same multivariable model.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"228-235"},"PeriodicalIF":1.8,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40370242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}